Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Impact Biomedical Inc.

NYSE: IBO · Life Sciences · 5 alerts · CIK 1834105

Share price
$4.91Close, Nov 16
Market cap
$42.4M
Shares outstanding
8.64MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Impact Biomedical Inc. filings on SEC EDGAR ↗

4:59 PM ET 8-K
Reverse Stock Split

Impact Biomedical Reverse Stock Split

Impact BioMedical Inc. implemented a 1-for-12.62 reverse stock split of its common stock effective September 23, 2026. The split reduced the number of outstanding shares from approximately 107.8 million to 8.6 million to adjust the company's capital structure. The stock began trading on a split-adjusted basis on the NYSE American under the existing ticker symbol 'IBO'.

6:04 AM ET 8-K
Reverse Stock Split

Impact Biomedical Reverse Stock Split

Impact Biomedical Inc. announced a 1-for-12.62 reverse stock split effective September 23, 2026, reducing outstanding shares from approximately 107.8 million to 8.5 million. The split is intended to regain compliance with NYSE American listing requirements and facilitate its proposed merger with Zoar Limited. Following the split and merger closing, Impact stockholders are expected to receive one share of Zoar Limited for every one share of Impact common stock held.

Counterparty
Zoar Limited

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.